Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Instagram Outage Disrupts Thousands of U.S. Users 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
NEW YORK, July 20, 2017 -- Gainey McKenna & Egleston announces that it has filed a derivative action (and a class action in the alternative) against Teva Pharmaceutical Industries Limited in the United States District Court for the Southern District of Ohio (Western Division). The action is brought on behalf of the Company’s Employee Stock Purchase Plan for U.S. Employees (“ESPP”), against certain Defendants to cover those persons who purchased or otherwise acquired Teva American Depository Shares (“ADSs”) between February 9, 2015 and November 3, 2016 (“Relevant Period”) in the ESPP. The action brings claims under § 11 of the Securities Act of 1933 as well as claims under state law for breach of fiduciary duty, non-disclosure and breach of contract.
If you wish to serve as lead plaintiff, you must move the Court no later than September 18, 2017. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
